You are here

Immunotherapy

A tumor sample from a human patient with the most common type of lung cancer (adenocarcinoma). Senescent cells are highlighted by their expression of the p16 (red) and the PD-L1 (green) proteins. Cell nuclei are in blue
21.10.2024

Weizmann Institute researchers reveal how aging cells evade our immune systems – and propose developing an innovative treatment for age-related...

Shutterstock
09.09.2024

A new Weizmann Institute approach promises to advance cancer immunotherapy; it increases the proliferation rate of cancer-targeting immune...

Combat team: A dendritic cell (right) and a T cell, both from a mouse with skin cancer, combined using the BiCE antibody (yellow)
18.01.2024

A new kind of immunotherapy, based on crosstalk between different immune cells, could pave the way for innovative treatments of cancer and...

Shutterstock
20.09.2023

Cancer alters cellular waste-processing machinery, helping it avoid detection by the immune system

Tissue sample of a particularly aggressive skin cancer reveals immune cells (yellow) that express on their surfaces a “brake pedal” receptor called FcgIIb (purple); cell nuclei are in blue
05.03.2023

Sometimes anticancer antibodies press on the gas and the brakes at the same time. New research might help them accelerate better

Natural anticancer antibodies (green) bound to a single ovarian tumor cell; the cell’s nucleus is in blue. Viewed with confocal microscopy
23.03.2022

Natural antibodies found in tumors could point the way toward improved immunotherapy 

Prof. Yardena Samuels
15.10.2021

Off-the-shelf therapies to be developed for entire groups of patients

How Cancers Hurt Themselves to Hurt Immune Cells More
16.12.2020

A study of melanoma cells explains a puzzling response they exhibit to ward off T cell attacks

immune cells in cancer
31.08.2020

A possible cause for cancer resistance to immunotherapy could be reversed

Pages